441 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $54.73 $95.26B Downtrend
ABT: BMO Capital Markets ups to Outperform http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20171215130248 Dec 15, 2017 - BMO Capital Markets issues rating change for ABT
New implantable heart monitor shares data with patient's smartphone http://www.startribune.com/business/464277103.html Dec 14, 2017 -
The Next 20 Dividend Achievers Absolutely Trounce The Market https://seekingalpha.com/article/4131977-next-20-dividend-achievers-absolutely-trounce-market?source=feed_all_articles Dec 14, 2017 - In 2015, I skimmed 15 of the largest Dividend Achievers.Many would say that due to the underperformance of the mega caps, I set myself up for some meager returns.So what if I had instead skipped over
Your Daily Pharma Scoop: Right Time To Buy Regeneron, Eli Lilly Gives Guidance, Bluebird Announces Offering https://seekingalpha.com/article/4131769-daily-pharma-scoop-right-time-buy-regeneron-eli-lilly-gives-guidance-bluebird-announces?source=feed_sector_healthcare Dec 14, 2017 - Regeneron is significantly undervalued at current levels. Eli Lilly has provided guidance for 2018. Bluebird has announced a public offering.
Analysts Take Action on Health Care Stocks http://www.gurufocus.com/news/610216/analysts-take-action-on-health-care-stocks Dec 13, 2017 - Analysts Take Action on Health Care Stocks, Stocks: ABT,AET,MDT,MYL, release date:Dec 13, 2017
I'm Sticking With CVS And Walgreens, My Last Two Losers https://seekingalpha.com/article/4131470-sticking-cvs-walgreens-last-two-losers?source=feed_all_articles Dec 13, 2017 - In early 2015 I created a portfolio (skimmed) from the Dividend Achievers Index.I selected 15 of the largest cap companies in that index.To date I've essentially tracked the returns of the underlying
Intersect ENT (XENT) SINUVA Implant Receives FDA Approval http://www.zacks.com/stock/news/285777/intersect-ent-xent-sinuva-implant-receives-fda-approval?cid=CS-ZC-FT-285777 Dec 13, 2017 - Intersect ENT's (XENT) consistent focus on the chronic sinusitis market is likely to lend the company a competitive edge in the niche space.
Abbott Laboratories Makes BMO Capital's Top Picks List http://feeds.benzinga.com/~r/benzinga/~3/FgIxNzHUWAk/abbott-laboratories-makes-bmo-capitals-top-picks-list Dec 12, 2017 -

Abbott Laboratories (NYSE: ABT) had a busy 2017 after acquiring Alere and St. Jude Medical, earning the stock a nod of approval from a Wall Street analyst.

Stocks making the biggest moves premarket: PEP, MAT, VZ, MYL & more https://www.cnbc.com/2017/12/12/stocks-making-the-biggest-moves-premarket-pep-mat-vz-myl-more.html Dec 12, 2017 - Names on the move ahead of the open.
Dividend Income Update November 2017 https://seekingalpha.com/article/4130833-dividend-income-update-november-2017?source=feed_all_articles Dec 10, 2017 - The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. No doubt, these are

Pages: 123456...45

Page 1>

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $86.5 $95.24B
BMY Bristol-Myers Squibb Company NYSE $62.13 $101.69B
GSK GlaxoSmithKline PLC NYSE $35.24 $86.67B
CELG Celgene Corporation NASDAQ $108.24 $85.22B
AZN Astrazeneca PLC NYSE $33.29 $84.29B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Abbott Laboratories
ABT - Google Finance https://www.google.com/finance?q=ABT Industry related info and international coverage Summary News
ABT - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ABT Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options